Alpine Global Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-47,723
| Closed | -$76K | – | 217 |
|
|
2022
Q4 | $76K | Buy |
47,723
+35,923
| +304% | +$57.2K | 0.03% | 365 |
|
|
2022
Q3 | $17K | Hold |
11,800
| – | – | ﹤0.01% | 169 |
|
|
2022
Q2 | $22K | Hold |
11,800
| – | – | 0.01% | 193 |
|
|
2022
Q1 | $32 | Sell |
11,800
-10,384
| -47% | -$28 | 0.01% | 333 |
|
|
2021
Q4 | $96K | Buy |
+22,184
| New | +$96K | 0.01% | 652 |
|
|
2020
Q1 | – | Sell |
-32,895
| Closed | -$273K | – | 272 |
|
|
2019
Q4 | $273K | Buy |
+32,895
| New | +$273K | 0.06% | 285 |
|